Rock Tech Lithium Welcomes Dr. Beate Degen to its Board of Directors
Rock Tech Lithium (TSXV: RCK) (OTCQX: RCKTF) has announced the appointment of Dr. Beate Degen to its Board of Directors, effective immediately. Dr. Degen brings extensive global expertise in strategy, innovation, sustainability, artificial intelligence, and risk management, with experience across commodities, life sciences, deep tech, and financial services sectors.
Dr. Degen's background includes senior strategic leadership and finance positions at Bayer AG, Ernst & Young, and various tech start-ups. Concurrent with this appointment, Klaus Schmitz, who has served since 2021 and played a key role in developing the company's first German lithium converter, has resigned from the Board of Directors.
Rock Tech Lithium (TSXV: RCK) (OTCQX: RCKTF) ha annunciato la nomina della Dr.ssa Beate Degen nel suo Consiglio di Amministrazione, con effetto immediato. La Dr.ssa Degen porta con sé una vasta esperienza globale in strategia, innovazione, sostenibilità, intelligenza artificiale e gestione del rischio, con esperienza nei settori delle materie prime, delle scienze della vita, della tecnologia avanzata e dei servizi finanziari.
Il background della Dr.ssa Degen include posizioni di leadership strategica senior e finanza presso Bayer AG, Ernst & Young e diverse start-up tecnologiche. Contestualmente a questa nomina, Klaus Schmitz, che ha servito dal 2021 e ha svolto un ruolo chiave nello sviluppo del primo convertitore di litio tedesco dell'azienda, si è dimesso dal Consiglio di Amministrazione.
Rock Tech Lithium (TSXV: RCK) (OTCQX: RCKTF) ha anunciado el nombramiento de la Dr. Beate Degen en su Junta Directiva, con efecto inmediato. La Dra. Degen aporta una amplia experiencia global en estrategia, innovación, sostenibilidad, inteligencia artificial y gestión de riesgos, con experiencia en los sectores de materias primas, ciencias de la vida, tecnología avanzada y servicios financieros.
El historial de la Dra. Degen incluye posiciones de liderazgo estratégico y financiero en Bayer AG, Ernst & Young y varias startups tecnológicas. Concurrentemente con este nombramiento, Klaus Schmitz, quien ha estado en el cargo desde 2021 y desempeñó un papel clave en el desarrollo del primer convertidor de litio alemán de la empresa, ha dimitido de la Junta Directiva.
록텍 리튬 (TSXV: RCK) (OTCQX: RCKTF)는 비아테 데겐 박사를 이사회의 새로운 이사로 즉시 임명했다고 발표했습니다. 데겐 박사는 전략, 혁신, 지속 가능성, 인공지능 및 리스크 관리 분야에서 광범위한 글로벌 전문성을 가지고 있으며, 원자재, 생명 과학, 딥 테크 및 금융 서비스 분야에서 경험을 쌓았습니다.
데겐 박사의 경력은 바이엘 AG, 언스트 앤 영 및 여러 기술 스타트업에서의 고위 전략적 리더십 및 재무 직책을 포함합니다. 이번 임명과 동시에 2021년부터 재직 중이던 클라우스 슈미츠는 회사의 첫 독일 리튬 변환기 개발에 중요한 역할을 했으며, 이사회에서 사임했습니다.
Rock Tech Lithium (TSXV: RCK) (OTCQX: RCKTF) a annoncé la nomination de Dr. Beate Degen au sein de son Conseil d'Administration, avec effet immédiat. Dr. Degen apporte une vaste expertise mondiale en stratégie, innovation, durabilité, intelligence artificielle et gestion des risques, avec une expérience dans les secteurs des matières premières, des sciences de la vie, des technologies avancées et des services financiers.
Le parcours de Dr. Degen inclut des postes de direction stratégique et financière chez Bayer AG, Ernst & Young et diverses start-ups technologiques. En parallèle de cette nomination, Klaus Schmitz, qui a été en fonction depuis 2021 et a joué un rôle clé dans le développement du premier convertisseur de lithium allemand de l'entreprise, a démissionné du Conseil d'Administration.
Rock Tech Lithium (TSXV: RCK) (OTCQX: RCKTF) hat die Ernennung von Dr. Beate Degen in seinen Vorstand bekannt gegeben, die sofort wirksam wird. Dr. Degen bringt umfassende globale Expertise in den Bereichen Strategie, Innovation, Nachhaltigkeit, künstliche Intelligenz und Risikomanagement mit, sowie Erfahrung in den Sektoren Rohstoffe, Lebenswissenschaften, Deep Tech und Finanzdienstleistungen.
Dr. Degens Hintergrund umfasst leitende strategische Führungs- und Finanzpositionen bei Bayer AG, Ernst & Young und verschiedenen Technologie-Start-ups. Zeitgleich mit dieser Ernennung hat Klaus Schmitz, der seit 2021 im Amt war und eine Schlüsselrolle bei der Entwicklung des ersten deutschen Lithiumwandlers des Unternehmens gespielt hat, seinen Rücktritt aus dem Vorstand erklärt.
- Appointment of experienced director with diverse expertise in strategy, innovation, and sustainability
- Addition of senior leadership experience from major companies like Bayer AG and Ernst & Young
- Enhanced board expertise in AI and risk management
- Loss of key board member Klaus Schmitz who was instrumental in German lithium converter project
Dr. Degen is an accomplished advisor, entrepreneur, and non-executive director with extensive global expertise spanning strategy & innovation, sustainability, artificial intelligence, and risk management. She brings diverse experience across industries including commodities, life sciences, deep tech, and financial services. Prior to building her portfolio of board roles, Dr. Degen held senior strategic leadership and finance positions at chemical-pharmaceutical giant Bayer AG, Ernst & Young as well as tech start-ups.
Simultaneously, Rock Tech announces the resignation of Klaus Schmitz from the Board of Directors.
"Welcoming Beate to Rock Tech's Board is a significant enhancement to our team. In today's constantly evolving business landscape, her extensive global expertise in strategic leadership and financing will be a valuable asset to the Company. I would also like to sincerely thank Klaus Schmitz who has been with the Company since 2021 for his dedicated work for Rock Tech in various positions, which has been essential in turning our vision of building the first German lithium converter into reality. We wish Klaus all the best for his future endeavours."
On behalf of the Board of Directors,
Dirk Harbecke
Chairman & CEO
ABOUT ROCK TECH
Rock Tech's vision is to supply the electric vehicle and battery industry with sustainable, locally produced lithium, targeting a
CAUTIONARY NOTE CONCERNING FORWARD-LOOKING INFORMATION
Certain statements contained in this news release constitute "forward-looking information" under applicable securities laws and are referred to herein as "forward-looking statements". All statements, other than statements of historical fact, which address events, results, outcomes or developments that the Company expects to occur are forward-looking statements. When used in this news release, words such as "expects", "anticipates", "plans", "predicts", "believes", "estimates", "intends", "targets", "projects", "forecasts", "may", "will", "should", "would", "could" or negative versions thereof and other similar expressions are intended to identify forward-looking statements. In particular, this news release contains forward-looking information pertaining to: the intended use of proceeds from the Offering and allocation thereof; listing of the Unit Shares on the TSX-V, including obtaining the final acceptance of the TSX-V; discussions with strategic and financial investors to explore potential opportunities for investments directly at the project level, including the Company's converter projects in
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
View original content to download multimedia:https://www.prnewswire.com/news-releases/rock-tech-lithium-welcomes-dr-beate-degen-to-its-board-of-directors-302421028.html
SOURCE Rock Tech Lithium Inc.
FAQ
Who is the new Board Director appointed to Rock Tech Lithium (RCKTF)?
What experience does Dr. Beate Degen bring to Rock Tech Lithium (RCKTF)?
Who resigned from Rock Tech Lithium's (RCKTF) Board of Directors?
What is Rock Tech Lithium's (RCKTF) progress on their German lithium converter?
